tiprankstipranks
Trending News
More News >
Maximus (MMS)
NYSE:MMS

Maximus (MMS) AI Stock Analysis

Compare
197 Followers

Top Page

MMS

Maximus

(NYSE:MMS)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$80.00
▼(-7.21% Downside)
Action:ReiteratedDate:03/12/26
The score reflects solid underlying financial quality (improving profitability, strong ROE, and improved leverage) and a reasonable valuation, partially offset by weak technical momentum and mixed near-term execution signals (revenue softness and cash/working-capital pressure). The earnings outlook is constructive due to raised FY2026 earnings and margin guidance, but contract timing and low book-to-bill keep risk elevated.
Positive Factors
Very low leverage and strong ROE
Extremely low debt relative to equity and a high ROE provide durable financial flexibility. This capital structure supports bid competitiveness, targeted investments, and resilience through award timing swings, reducing refinancing risk and enabling opportunistic M&A or technology spending over the next 2–6 months.
Sustained margin expansion and guided improvement
Management has raised full-year margin and EPS guidance backed by demonstrated Q1 margin gains. Structural productivity gains from technology and process improvements appear to be lifting segment economics, implying more durable EBITDA margin expansion rather than a one-off seasonal spike.
Large pipeline and AI/product proofs driving future revenue
A materially expanded pipeline, plus AI/automation proof points and product launches, increase multi-quarter visibility for contract awards. Automation wins that boost throughput and accuracy can sustainably raise productivity and program margins as tracked proposals convert over the medium term.
Negative Factors
Near-term revenue softness
Revenue declines and negative trailing revenue growth reflect reduced near-term demand or timing of awards. Slower top-line trends limit the company's ability to leverage fixed costs, compress long-run growth expectations, and make margins more dependent on cost control rather than organic expansion.
Working-capital and cash-flow pressure
Elevated receivables and a quarter of negative operating and free cash flow signal structural working-capital strain. Persistent collection delays or seasonally high DSO can force short-term borrowing, constrain bid funding, and limit reinvestment capacity across the business for several quarters.
Award timing, low book-to-bill and contract uncertainty
Very low quarterly book-to-bill and outstanding protests create meaningful revenue conversion risk. Dependency on award timing in government procurement reduces near-term visibility and means that sizable pipeline gains may not translate into revenue within the upcoming fiscal year.

Maximus (MMS) vs. SPDR S&P 500 ETF (SPY)

Maximus Business Overview & Revenue Model

Company DescriptionMaximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Tysons, Virginia.
How the Company Makes MoneyMaximus makes money primarily by performing outsourced services for government clients under contractual arrangements. Its revenue is largely generated from government contracts (e.g., federal, state, local, and international government agencies) to administer, operate, and improve public programs. These contracts typically compensate Maximus through (1) service fees tied to staffing and operations (often structured as fixed-price, time-and-materials, or cost-reimbursable arrangements depending on contract terms), (2) transaction- or volume-based fees linked to measurable units of work (such as calls handled, cases processed, or beneficiaries served), and (3) performance-based incentives or award fees when it meets or exceeds contractual service-level metrics and outcomes (for example, timeliness, quality, or other program KPIs). Significant factors influencing earnings include the scale and duration of awarded government contracts, renewals and recompetes, the company’s ability to meet performance requirements to earn incentive fees, and its cost management in delivering services. Specific details on individual contract pricing, margin structure by contract type, or named partnerships not publicly disclosed are null.

Maximus Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The call presents a cautiously positive outlook: management reported solid Q1 adjusted profitability metrics, raised full-year earnings and margin guidance, highlighted meaningful pipeline growth, and showcased AI/product momentum and strategic wins (GSA BPA, AI dispute automation, Accuracy Assistant, Forbes recognition). Counterbalancing these positives are near-term revenue declines (Q1 revenue down 4.1%), softness in US Services and Outside-the-US segments, low book-to-bill in the quarter (0.2x), and seasonal / timing-driven cash outflows and elevated DSO. Management attributes many negatives to timing (government shutdown effects, expected award timing shifts) and positioned FY26 as a year of durable margins while expecting new work to contribute more meaningfully in FY27–FY28. Overall, the positives (guidance raise, margin expansion, pipeline growth, AI wins) outweigh the near-term operational and cash timing challenges.
Q1-2026 Updates
Positive Updates
Raised Full-Year Earnings Guidance and Improved Margin Outlook
Adjusted EPS guidance increased by $0.10 to a range of $8.05–$8.35 (midpoint $8.20), implying >11% year-over-year earnings growth at the midpoint. Full-year adjusted EBITDA margin guidance improved by ~30 basis points to approximately 14%.
Q1 Profitability Improvement (Adjusted)
Q1 adjusted EBITDA margin rose to 12.7% from 11.2% a year ago. Adjusted EPS for the quarter was $1.85 versus $1.61 in the prior year, reflecting margin and earnings improvement despite revenue decline.
US Federal Services: Organic Growth and Margin Expansion
US Federal Services revenue of $787M increased 0.8% year-over-year (organic growth). Segment operating margin expanded to 16.5% from 12.7% in the prior year, driven by technology initiatives improving staff productivity; full-year segment margin guidance raised to 16.5%–17% (up 100 basis points).
Pipeline and Proposal Activity Increased
Total pipeline grew to $59.1B (from $51.3B at 9/30). Proposals pending ($3.8B) plus proposals in preparation ($2.4B) combined to $6.2B, a 55% increase from $4.0B a year ago — indicating growing near-term opportunity funnel.
Strategic Wins and AI/Automation Proof Points
Won a major GSA BPA (single awardee) to support GXCC transformation (subject to protest) and an outside-the-US technology bid where Maximus scored ~98% of technical points. AI-driven dispute processing resolved 45% of disputes autonomously, materially increasing throughput and improving financial performance on that program.
Product Launches Targeting SNAP/MEDICAID Opportunities
Launched 'Accuracy Assistant,' an AI-powered tool to help states reduce SNAP payment error rates by detecting data inconsistencies and flagging potential errors in real time; CMS named Maximus one of 10 companies pledging support for Medicaid community engagement implementation.
Strategic Portfolio Actions and Recognition
Completed divestiture of a $25M-annual-revenue child support business recognizing a ~$9M gain to free capacity for higher-value state/federal work. Company named to Forbes' America's Best Employers 2026 list for the second consecutive year.
Maintained Free Cash Flow Guidance and Leverage Discipline
Despite Q1 cash outflow, full-year free cash flow guidance remains $450M–$500M. Total debt ended at $1.58B with consolidated net leverage of 1.8x (below stated 2–3x target); management expects to finish FY26 at or below 1.0x absent M&A or repurchases.
Negative Updates
Revenue Decline in Q1
Total Q1 revenue was $1.35B, down 4.1% year-over-year. Revenue headwinds were primarily organic after accounting for a ~1.5% impact from a prior period outside-the-US divestiture.
US Services Segment Contraction and Margin Pressure
US Services revenue decreased to $415M from $452M (a decline of ~8.2% year-over-year). Segment operating margin fell to 7.1% from 9.0%, with Q1 margin historically depressed due to seasonality and higher resource needs during open enrollment periods.
Outside-the-US Revenue Decline and Operating Loss
Outside-the-US revenue dropped to $143M from $170M (down ~15.9% year-over-year), driven partly by prior divestitures; the segment recorded an operating loss of $1.4M versus an $8.1M operating profit in the prior year period.
Weak Award Environment / Low Book-to-Bill
Signed awards for FY2026 totaled $246M with $699M awarded but unsigned; trailing twelve-month book-to-bill was ~0.5x and quarterly book-to-bill only 0.2x due to very light award activity in Q1 — management attributes this to timing impacts from government shutdown and expects award timing to normalize later in the year.
Q1 Cash Flow Outflows and Elevated DSO
Cash used in operations was a net outflow of $244M and free cash flow was a net outflow of $251M in Q1. Days sales outstanding rose to 78 days due to administrative delays in collections (including shutdown-related aftereffects); temporary borrowing increased leverage from 1.5x to 1.8x.
Limited Near-Term Contribution from New Work
Management's FY2026 guidance assumes virtually no contribution from new work; delays in award activity prompted a $50M reduction at the top end of revenue guidance, signaling that new contract revenue is expected to materialize more in FY27 and FY28.
Contract and Award Uncertainty
Some major awards remain subject to timing and protest risk (e.g., the GSA BPA is subject to the regulatory protest period). Additionally, award timing slowed after the government shutdown, creating short-term uncertainty for federal award cadence.
Company Guidance
Maximus raised FY‑2026 earnings guidance while narrowing revenue guidance to $5.20B–$5.35B, now targeting adjusted EBITDA of ~14% (up 30 bps) and adjusted EPS $8.05–$8.35 (midpoint $8.20, >11% YoY); free cash flow guidance is unchanged at $450M–$500M, interest expense is expected to be roughly $75M and the tax rate 24.5%–25.5%. Q1 results that informed the update included revenue $1.35B (‑4.1% YoY), adjusted EBITDA margin 12.7% and adjusted EPS $1.85, with cash used in operations of $244M and free cash flow outflow of $251M driving DSO to 78 days; total debt was $1.58B and consolidated net leverage 1.8x (down from 1.5x at 9/30 but still below the 2–3x target and expected to finish FY‑26 at or below 1.0x absent M&A or buybacks). Segment and pipeline metrics cited: Q1 US Federal revenue $787M (+0.8%) with a 16.5% segment margin (FY guide 16.5%–17%), US Services revenue $415M with a Q1 margin of 7.1% (FY guide 10.5%–11%), Outside US revenue $143M with an estimated FY margin of 13%; signed awards totaled $246M with $699M awarded but not signed, a TTM book‑to‑bill of ~0.5x (Q1 quarterly 0.2x), and a pipeline of $59.1B (including $3.8B proposals pending, $2.4B in preparation, $52.9B tracked, 59% new work; $6.2B proposals pending+prep, +55% YoY).

Maximus Financial Statement Overview

Summary
Profitability and returns are solid (TTM net margin ~6.9%, ROE ~21.8%) and leverage looks much improved (TTM debt-to-equity ~0.04). Offsetting this, growth has softened (TTM revenue ~-1.1%) and cash flow momentum weakened (TTM FCF down ~-40% and low OCF-to-net-income ~0.44), which reduces near-term financial momentum.
Income Statement
74
Positive
Profitability has improved meaningfully versus prior years, with TTM (Trailing-Twelve-Months) margins showing solid execution (gross margin ~23.8%, EBITDA margin ~12.9%, net margin ~6.9%) and EBIT/EBITDA dollars trending higher than earlier periods. However, growth has softened: annual revenue growth was modest in FY2025 (~2.4%) and TTM (Trailing-Twelve-Months) revenue is down (~-1.1%), which limits the quality of the earnings momentum despite better margins.
Balance Sheet
82
Very Positive
Leverage has improved sharply in the latest period, with very low debt relative to equity in TTM (Trailing-Twelve-Months) (debt-to-equity ~0.04) versus materially higher leverage in prior annual periods (~0.69–1.15). Equity remains sizable (~$1.72B) and returns are strong (TTM (Trailing-Twelve-Months) return on equity ~21.8%), supporting balance-sheet strength. The key watch item is the large year-to-year swing in total debt versus the annual figures, which suggests capital structure changed significantly and bears monitoring for sustainability.
Cash Flow
60
Neutral
Cash generation is positive, with TTM (Trailing-Twelve-Months) free cash flow of ~$218M and free cash flow running at ~82% of net income, indicating earnings are reasonably backed by cash. That said, TTM (Trailing-Twelve-Months) operating cash flow relative to net income is weak (~0.44), and free cash flow has declined sharply in the latest period (TTM (Trailing-Twelve-Months) free cash flow growth ~-40%), pointing to higher cash needs or working-capital pressure versus the prior year.
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue5.37B5.43B5.31B4.90B4.63B4.25B
Gross Profit1.26B1.25B1.16B934.02M849.35M902.62M
EBITDA723.27M674.75M624.28M456.45M464.76M502.74M
Net Income371.78M319.03M306.91M161.79M203.83M291.20M
Balance Sheet
Total Assets4.21B4.07B4.13B3.99B3.99B4.12B
Cash, Cash Equivalents and Short-Term Investments137.59M260.46M235.76M122.09M136.79M156.57M
Total Debt1.74B1.44B1.28B1.43B1.51B1.71B
Total Liabilities2.49B2.40B2.29B2.32B2.44B2.64B
Stockholders Equity1.72B1.67B1.84B1.67B1.55B1.48B
Cash Flow
Free Cash Flow218.48M366.16M401.07M223.65M233.69M480.76M
Operating Cash Flow264.97M429.37M515.26M314.34M289.84M517.32M
Investing Cash Flow-31.37M-60.26M-129.10M-80.96M-54.01M-1.84B
Financing Cash Flow-178.72M-343.88M-275.65M-250.80M-248.27M1.39B

Maximus Technical Analysis

Technical Analysis Sentiment
Negative
Last Price86.22
Price Trends
50DMA
83.69
Negative
100DMA
84.01
Negative
200DMA
81.50
Negative
Market Momentum
MACD
-2.57
Negative
RSI
36.80
Neutral
STOCH
11.53
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MMS, the sentiment is Negative. The current price of 86.22 is above the 20-day moving average (MA) of 74.63, above the 50-day MA of 83.69, and above the 200-day MA of 81.50, indicating a bearish trend. The MACD of -2.57 indicates Negative momentum. The RSI at 36.80 is Neutral, neither overbought nor oversold. The STOCH value of 11.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MMS.

Maximus Risk Analysis

Maximus disclosed 37 risk factors in its most recent earnings report. Maximus reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Maximus Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$4.75B21.896.45%0.71%0.20%2.72%
68
Neutral
$10.63B25.0210.17%1.14%6.35%24.07%
67
Neutral
$3.90B12.6021.76%1.38%2.36%11.30%
64
Neutral
$2.24B17.898.80%2.20%4.62%102.72%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
$1.86B-72.27-2.68%93.41%-2515.85%
60
Neutral
$1.46B27.646.21%59.19%-35.47%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MMS
Maximus
72.09
4.61
6.84%
ABM
ABM Industries
38.16
-7.68
-16.75%
CBZ
CBIZ
26.49
-45.55
-63.23%
UNF
UniFirst
273.42
68.80
33.62%
ARMK
ARAMARK Holdings
40.87
6.38
18.51%
FA
First Advantage
10.68
-2.77
-20.59%

Maximus Corporate Events

Executive/Board ChangesShareholder Meetings
Maximus Shareholders Back Board, Executive Pay and Auditor
Positive
Mar 12, 2026

At its Annual Meeting of Shareholders held on March 10, 2026, Maximus, Inc. reported that 93.2% of outstanding common stock was represented, and shareholders elected eight directors, including CEO Bruce L. Caswell, to one-year terms expiring at the 2027 annual meeting. Investors also ratified the appointment of KPMG LLP as independent auditor for the 2026 fiscal year and approved, on an advisory basis, the compensation of the company’s named executive officers, signaling broad shareholder support for current leadership, governance structure, and financial oversight.

These voting outcomes suggest continuity in Maximus’s strategic direction and executive team, which may reassure stakeholders about the stability of its operations and governance framework. The strong support for the board slate, executive pay program, and external auditor underscores shareholder confidence in how the company is being managed and its approach to financial reporting and oversight.

The most recent analyst rating on (MMS) stock is a Hold with a $82.00 price target. To see the full list of analyst forecasts on Maximus stock, see the MMS Stock Forecast page.

Executive/Board Changes
Maximus Announces Upcoming Chief Legal Officer Transition
Neutral
Dec 18, 2025

On December 15, 2025, Maximus, Inc. announced that its Chief Legal Officer and Corporate Secretary, John T. Martinez, has notified the company of his intention to resign effective February 15, 2026, to pursue a new opportunity more closely aligned with his industry background and experience. The company stated that the decision was not the result of any disagreement over operations, policies, or practices, and Martinez will remain in his current role until his departure while Maximus conducts a search for his replacement, signaling an orderly legal and governance leadership transition.

The most recent analyst rating on (MMS) stock is a Buy with a $93.00 price target. To see the full list of analyst forecasts on Maximus stock, see the MMS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026